FDA approves flu drug from Durham pharmaceutical company – WNCN


CIDRAP
FDA approves flu drug from Durham pharmaceutical company
WNCN
Biocryst Pharmaceuticals CEO Jon Stonehouse can proudly talk about Rapivab, a now FDA-approved antiviral drug that will treat some flu cases. “There were many times where we could have given up and said this is just not going to make it. And we didn’t.
BioCryst gets FDA approval for RAPIVAB to treat acute uncomplicated influenzaPharmaceutical Business Review

all 68 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd